HOME › DRUGS › TISLELIZUMAB
ACTIVE SUBSTANCE / INN

TISLELIZUMAB

Brand name(s): Tevimbra, Tizveni
EMA LISTED
WITHDRAWN
AUTHORISED
Carcinoma, Non-Small-Cell Lung
Esophageal Squamous Cell Carcinoma;Carcinoma, Non-Small-Cell…
ACTIVE SUBSTANCE
Tislelizumab
REGULATORS
EMA
SPONSORS / MAH
Beone Medicines Ireland Limited, BeiGene Ireland Ltd
TOTAL APPLICATIONS
2
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
TevimbraBeone Medicines Ireland LimitedAuthorised15/09/2023Esophageal Squamous Cell Carcinoma;Carcinoma, Non-Small-Cell Lung;Small Cell Lun…
TizveniBeiGene Ireland LtdWithdrawn19/04/2024Carcinoma, Non-Small-Cell Lung

FULL INTELLIGENCE ON TISLELIZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →